Jesper Pilmeyer

Jesper Pilmeyer is a University Researcher in the Department of Electrical Engineering at Eindhoven University of Technology, specializing in neuroscience applications of signal processing and medical imaging. His work focuses on functional MRI analysis for brain network modeling in psychiatric conditions, particularly major depressive disorder and autism spectrum disorder, contributing to UN Sustainable Development Goal 3 (Good Health and Well-being).

Education:

• PhD in Electrical Engineering, Eindhoven University of Technology (2025)
• MSc in Electrical Engineering, Eindhoven University of Technology (2018)

Research Focus: Pilmeyer develops advanced computational methods for multi-echo fMRI data analysis, emphasizing biomarker identification for depression treatment prediction and autism brain network characterization. His expertise spans independent component analysis, brain network dynamics modeling, and machine learning applications in neurodiagnostics, bridging electrical engineering with clinical neuroscience to improve objective diagnostic frameworks.

Publication Trends: Recent work demonstrates a concentrated effort on translating fMRI network analysis into clinical tools, with 2024-2025 publications showing progression from methodological development (multi-echo combinations) to clinical applications (depression prognosis, autism comparisons) using large datasets like ABIDE. Key themes include explainable AI for depression classification and causal network modeling in neurodevelopmental disorders.

Research Affiliations: Active in the Biomedical Diagnostics Lab, NeuroPlatform, and Eindhoven MedTech Innovation Center, where he contributes to interdisciplinary projects integrating signal processing with medical diagnostics. His work has received media coverage including news outlets and research blogs, with presentations at scientific conferences in 2023 on depression prognosis and multi-echo fMRI applications.

Professional Activities: Delivered contributed talks on depression prediction (2023) and participated in press engagements regarding depression diagnostics. No formal advising roles or grant information is documented in available sources.